Search results
Results from the WOW.Com Content Network
Cover of the European Pharmacopoeia, 11th Edition. The European Pharmacopoeia [1] (Pharmacopoeia Europaea, Ph. Eur.) is a major regional pharmacopoeia which provides common quality standards throughout the pharmaceutical industry in Europe to control the quality of medicines, and the substances used to manufacture them. [1]
The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a Directorate and partial agreement of the Council of Europe that traces its origins and statutes to the Convention on the Elaboration of a European Pharmacopoeia (an international treaty adopted by the Council of Europe in 1964: ETS 50, [2] Protocol [3]).
A pharmacopoeia, pharmacopeia, or pharmacopoea (from the obsolete typography pharmacopœia, meaning "drug-making"), in its modern technical sense, is a book containing directions for the identification of compound medicines, and published by the authority of a government or a medical or pharmaceutical society.
Pharmacopeial reference standards are available from various pharmacopoeias such as United States Pharmacopeia and the European Pharmacopoeia. Where pharmacopoeial tests or assays call for the use of a pharmacopoeial reference standard, only those results obtained using the specified pharmacopoeial reference standard are conclusive.
Manage the Clinical Practice Research Datalink and the British Pharmacopoeia. The MHRA hosts and supports a number of expert advisory bodies, including the British Pharmacopoeia Commission, and the Commission on Human Medicine which replaced the Committee on the Safety of Medicines in 2005. [citation needed]
Since 1997, European Pharmacopoeia has been in force in the Republic of Slovenia. [2] The alignment of provisions of the national law in the field of medicinal products and regulations at the level of the European Pharmacopoeia brought forward the need for Slovenian addendum to the European Pharmacopoeia.
In the view of the historian Paula De Vos, De materia medica formed the core of the European pharmacopoeia until the end of the 19th century, suggesting that "the timelessness of Dioscorides' work resulted from an empirical tradition based on trial and error; that it worked for generation after generation despite social and cultural changes and ...
European Agreement on Regulations governing the Movement of Persons between Member States of the Council of Europe: 13-Dec-1957: 1-Jan-1958: yes: yes: no 026: European Agreement on the Exchange of Therapeutic Substances of Human Origin: 15-Dec-1958: 1-Jan-1959: yes: yes: yes 027: European Agreement concerning Programme Exchanges by means of ...